Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schwartz

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Veterinary Pharmacology and Therapeutics|May 23, 1998
Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypesD D Schwartz, T P Clark
Journal of Veterinary Pharmacology and Therapeutics|November 12, 1998
Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheepD D Schwartz, T P Clark
Life Sciences|January 1, 1991
Effects of synthetic ANF (rANF(3-28)) on sympathetic neurotransmission in the isolated perfused rat kidneyD D Schwartz, D C Eikenburg
Journal of Neurochemistry|September 1, 1991
Mechanism of neurotransmitter release elicited by the preferential alpha 1-adrenergic receptor agonist phenylephrine in superfused superior cervical ganglion cells in cultureD D Schwartz, K U Malik
The American Journal of Physiology|September 1, 1993
Contribution of calcium to isoproterenol-stimulated lipolysis in the isolated perfused rabbit heartD D Schwartz, J L Williams, K U Malik
Neuroscience|May 1, 1994
Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion cells by restricting the availability of calcium through a pertussis toxin-sensitive mechanismW F Oellerich, D D Schwartz, K U Malik
The American Journal of Physiology|July 31, 1998
ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulationJ R Henegar, D D Schwartz, J S Janicki
Journal of Veterinary Pharmacology and Therapeutics|January 29, 2000
Molecular and pharmacological characterization of the canine brainstem alpha-2A adrenergic receptorD D Schwartz, W G Jones, K P Hedden, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 31, 2003
Pharmacologic identification of putative D1 dopamine receptors in feline kidneysW S Flournoy, J S Wohl, T J Albrecht-Schmitt, et al.
Domestic Animal Endocrinology|October 12, 2000
Reduced growth of calves and its reversal by use of anabolic agentsJ L Sartin, M A Shores, D D Schwartz, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Veterinary Pharmacology and Therapeutics|May 23, 1998
Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypesD D Schwartz, T P Clark
Journal of Veterinary Pharmacology and Therapeutics|November 12, 1998
Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheepD D Schwartz, T P Clark
Life Sciences|January 1, 1991
Effects of synthetic ANF (rANF(3-28)) on sympathetic neurotransmission in the isolated perfused rat kidneyD D Schwartz, D C Eikenburg
Journal of Neurochemistry|September 1, 1991
Mechanism of neurotransmitter release elicited by the preferential alpha 1-adrenergic receptor agonist phenylephrine in superfused superior cervical ganglion cells in cultureD D Schwartz, K U Malik
The American Journal of Physiology|September 1, 1993
Contribution of calcium to isoproterenol-stimulated lipolysis in the isolated perfused rabbit heartD D Schwartz, J L Williams, K U Malik
Neuroscience|May 1, 1994
Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion cells by restricting the availability of calcium through a pertussis toxin-sensitive mechanismW F Oellerich, D D Schwartz, K U Malik
The American Journal of Physiology|July 31, 1998
ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulationJ R Henegar, D D Schwartz, J S Janicki
Journal of Veterinary Pharmacology and Therapeutics|January 29, 2000
Molecular and pharmacological characterization of the canine brainstem alpha-2A adrenergic receptorD D Schwartz, W G Jones, K P Hedden, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 31, 2003
Pharmacologic identification of putative D1 dopamine receptors in feline kidneysW S Flournoy, J S Wohl, T J Albrecht-Schmitt, et al.
Domestic Animal Endocrinology|October 12, 2000
Reduced growth of calves and its reversal by use of anabolic agentsJ L Sartin, M A Shores, D D Schwartz, et al.
Pageof 3